Exchange: NASDAQ·Updated 01:17 PM EST

ZJYL Jin Medical International Ltd

$3.42
$0.045
(1.33%)
Today
EarningsJan 23
Mkt Cap$533.91M
Vol2,757.00

About ZJYL

Jin Medical International Ltd. is a holding company. It is engaged in the design, development, manufacturing, and sale of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The company was founded on January 14, 2020 and is headquartered in Changzhou, China.
42

Bearish Sentiment

How do you feel about ZJYL?

Frankiy
$ZJYL gonna trigger a golden cross (MA50 crosses the MA200) next week imo. Gonna let you know...
1
Frankiy
$ZJYL 4.91 close +16.63% The stock has closed above the 2nd band on the daily chart. The bids have been bigger in size also today.
1
Frankiy
$ZJYL Tomorrow we gonna go for the $4.50-4.80 area imo. If it breaks that $4.80 are it gonna see a bigger pop...
1
PoseidonCalls
Short sellers are ruining american small caps and driving companies into bankruptcy!! FMFC has barely 800 watchers on Stocktwits and has been shorted down to only 1.5 million market cap. You could literally buy the ENTIRE company! Webull data stating that FMFC has only 492k shares outstanding and 243k shares float. Watch FMFC here. Making a move 🚀 💎 👀 $ZJYL $APP trending
focafoca99
$ZJYL opened a four-stop global expo tour, debuting new lightweight wheelchairs across China, ASEAN and Europe.
focafoca99
$ZJYL recorded the completion of its Kangma equity transfer, confirming no additional shares will be issued.
a_s_a_p_Bevo
$ZJYL for the amount of vol, the run and catch was/ is pretty strong...do the same to FRGT lol
sangju
$ZJYL Everywhere you look, there’s "good news" popping up—but instead of a bull market, it’s just a dumpster fire, lol.
sangju
$ZJYL I analyzed the article as good news. Gene Medical International announced that it has completed a VIE-based acquisition of Beijing Chenglan Kangxu Technology. This acquisition expanded Jin Medical's medical technology business network and strengthened its China-centric growth strategy through financing. This transaction is a capital-light expansion strategy that signals potential changes in investor governance dynamics and liquidity.

Advertisement|Remove ads.